Vir Biotechnology, Inc. VIR Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s income tax?
- Vir Biotechnology, Inc. (VIR) reported income tax of $170K in Q1 2026.
- How has Vir Biotechnology, Inc.'s income tax changed year-over-year?
- Vir Biotechnology, Inc.'s income tax increased by 962.5% year-over-year, from $16K to $170K.
- What is the long-term trend for Vir Biotechnology, Inc.'s income tax?
- Over 2 years (2021 to 2024), Vir Biotechnology, Inc.'s income tax has grown at a -76.8% compound annual growth rate (CAGR), from $21.22M to -$1.15M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.